DLB Earnings & Financial Statements
Dolby Laboratories, Inc.
$60.39
+$1.55(+2.63%)
50
Overall
95
Value
10
Tech
47
Quality
Market Cap
$5.47B
Volume
76.84K
52W Range
$48.26 - $69.95
Target Price
$74.25
DLB earnings and financial statements: Dolby Laboratories, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
DLB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B |
| Cost of revenue | $160.13M | - | - | - | $130.03M |
| Operating income | $279.97M | $258.33M | $215.75M | $206.60M | $344.39M |
| EBITDA | $385.23M | $363.24M | $316.49M | $319.28M | $453.52M |
| Net income | $255.02M | $261.82M | $200.66M | $184.09M | $310.23M |
| EPS (diluted) | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B |
| Total liabilities | $595.81M | $623.03M | $607.58M | $438.53M | $501.45M |
| Shareholders’ equity | $2.62B | $2.48B | $2.36B | $2.25B | $2.60B |
| Cash and equivalents | $701.89M | $482.05M | $745.36M | $620.13M | $1.23B |
| Long-term debt | $28.49M | $34.75M | $37.02M | $37.69M | $56.72M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $472.20M | $327.25M | $367.08M | $318.58M | $447.75M |
| Capital expenditure | -$41.94M | -$30.01M | -$30.34M | -$59.46M | -$38.09M |
| Free cash flow | $435.85M | $297.25M | $336.74M | $259.12M | $409.66M |
| Dividends paid | $128.45M | $119.74M | $103.67M | $101.50M | $96.53M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DLB | $60.39 | +2.6% | 76.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dolby Laboratories, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW